Concepts (133)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
Ventriculostomy | 1 | 2017 | 8 | 0.73 | Why? |
Cerebrospinal Fluid Leak | 1 | 2017 | 55 | 0.68 | Why? |
Hydrocephalus | 1 | 2017 | 139 | 0.65 | Why? |
Drainage | 1 | 2017 | 414 | 0.53 | Why? |
Catheter-Related Infections | 1 | 2017 | 381 | 0.51 | Why? |
Staphylococcal Infections | 2 | 2017 | 1099 | 0.39 | Why? |
Homosexuality, Male | 1 | 2018 | 1158 | 0.37 | Why? |
Pre-Exposure Prophylaxis | 1 | 2018 | 1138 | 0.37 | Why? |
Republic of Korea | 12 | 2021 | 5858 | 0.36 | Why? |
Sexual and Gender Minorities | 1 | 2018 | 1019 | 0.35 | Why? |
Hypoxia | 1 | 2020 | 3626 | 0.29 | Why? |
Infectious Disease Medicine | 2 | 2020 | 311 | 0.22 | Why? |
Patient Acceptance of Health Care | 1 | 2018 | 5002 | 0.19 | Why? |
Postoperative Complications | 1 | 2017 | 5861 | 0.19 | Why? |
Respiratory Insufficiency | 1 | 2020 | 7301 | 0.19 | Why? |
Staphylococcus hominis | 1 | 2017 | 2 | 0.18 | Why? |
Cerebral Intraventricular Hemorrhage | 1 | 2017 | 4 | 0.18 | Why? |
Scrub Typhus | 1 | 2019 | 68 | 0.18 | Why? |
Staphylococcus epidermidis | 1 | 2017 | 53 | 0.17 | Why? |
Bunyaviridae Infections | 1 | 2019 | 107 | 0.17 | Why? |
Respiration, Artificial | 4 | 2021 | 22116 | 0.17 | Why? |
Emtricitabine | 1 | 2018 | 202 | 0.17 | Why? |
Proteoglycans | 1 | 2018 | 130 | 0.17 | Why? |
Phlebotomus Fever | 1 | 2016 | 44 | 0.16 | Why? |
Tick-Borne Diseases | 1 | 2016 | 68 | 0.15 | Why? |
Human Umbilical Vein Endothelial Cells | 1 | 2018 | 286 | 0.15 | Why? |
Health Knowledge, Attitudes, Practice | 1 | 2018 | 8811 | 0.14 | Why? |
Tenofovir | 1 | 2018 | 449 | 0.14 | Why? |
Sexual Partners | 1 | 2018 | 612 | 0.12 | Why? |
HIV Infections | 1 | 2018 | 11620 | 0.12 | Why? |
Subarachnoid Hemorrhage | 1 | 2017 | 611 | 0.11 | Why? |
C-Reactive Protein | 3 | 2020 | 7972 | 0.09 | Why? |
Sexual Behavior | 1 | 2018 | 1322 | 0.09 | Why? |
Diabetes Complications | 1 | 2020 | 2358 | 0.09 | Why? |
Ventilators, Mechanical | 1 | 2020 | 2193 | 0.09 | Why? |
Health Personnel | 1 | 2018 | 29646 | 0.09 | Why? |
Disaster Planning | 1 | 2020 | 1680 | 0.09 | Why? |
Phlebovirus | 2 | 2019 | 106 | 0.08 | Why? |
Angiotensin-Converting Enzyme Inhibitors | 2 | 2020 | 5277 | 0.07 | Why? |
Methicillin Resistance | 1 | 2005 | 77 | 0.07 | Why? |
Risk Factors | 6 | 2021 | 71621 | 0.07 | Why? |
Anti-HIV Agents | 1 | 2018 | 2209 | 0.07 | Why? |
Seroepidemiologic Studies | 1 | 2021 | 10017 | 0.07 | Why? |
Pneumonia, Viral | 7 | 2020 | 243684 | 0.07 | Why? |
Aged, 80 and over | 6 | 2021 | 88759 | 0.07 | Why? |
Renin-Angiotensin System | 1 | 2020 | 3661 | 0.07 | Why? |
Coronavirus Infections | 7 | 2020 | 253789 | 0.07 | Why? |
Angiotensin Receptor Antagonists | 1 | 2020 | 3892 | 0.07 | Why? |
Aged | 11 | 2021 | 215776 | 0.06 | Why? |
Diagnosis, Differential | 1 | 2018 | 7220 | 0.06 | Why? |
Adenosine Monophosphate | 1 | 2021 | 5652 | 0.06 | Why? |
Alanine | 1 | 2021 | 5687 | 0.06 | Why? |
Disease Outbreaks | 2 | 2021 | 27595 | 0.06 | Why? |
Middle Aged | 12 | 2021 | 270681 | 0.06 | Why? |
Male | 12 | 2021 | 367725 | 0.06 | Why? |
Physicians | 1 | 2020 | 4214 | 0.05 | Why? |
Sepsis | 1 | 2018 | 3517 | 0.05 | Why? |
Lymphocytosis | 1 | 2020 | 122 | 0.05 | Why? |
Orientia tsutsugamushi | 1 | 2019 | 45 | 0.05 | Why? |
Adult | 8 | 2021 | 244371 | 0.05 | Why? |
Age Factors | 1 | 2020 | 21039 | 0.05 | Why? |
Random Allocation | 1 | 2021 | 773 | 0.05 | Why? |
Humans | 19 | 2021 | 930598 | 0.05 | Why? |
Staphylococcus aureus | 1 | 2005 | 844 | 0.05 | Why? |
Female | 10 | 2021 | 380317 | 0.04 | Why? |
Proportional Hazards Models | 2 | 2021 | 6543 | 0.04 | Why? |
Diabetes Mellitus | 1 | 2020 | 8207 | 0.04 | Why? |
Multivariate Analysis | 2 | 2020 | 5440 | 0.04 | Why? |
Meningitis, Viral | 1 | 2018 | 97 | 0.04 | Why? |
Leukopenia | 1 | 2019 | 280 | 0.04 | Why? |
Tuberculosis, Meningeal | 1 | 2018 | 100 | 0.04 | Why? |
Treatment Outcome | 2 | 2020 | 51732 | 0.04 | Why? |
Retrospective Studies | 4 | 2021 | 105322 | 0.04 | Why? |
Ticks | 1 | 2016 | 107 | 0.04 | Why? |
Thrombocytopenia | 2 | 2020 | 2093 | 0.04 | Why? |
Pandemics | 8 | 2020 | 389249 | 0.04 | Why? |
Influenza, Human | 1 | 2020 | 10779 | 0.04 | Why? |
Dipeptidyl-Peptidase IV Inhibitors | 1 | 2020 | 436 | 0.04 | Why? |
Hospitalization | 3 | 2021 | 54280 | 0.04 | Why? |
Cross Infection | 1 | 2016 | 8675 | 0.03 | Why? |
Surveys and Questionnaires | 2 | 2020 | 43792 | 0.03 | Why? |
Geography | 1 | 2020 | 1801 | 0.03 | Why? |
Alanine Transaminase | 1 | 2020 | 1329 | 0.03 | Why? |
Logistic Models | 2 | 2020 | 9089 | 0.03 | Why? |
Intensive Care Units | 1 | 2020 | 29594 | 0.03 | Why? |
Aspartate Aminotransferases | 1 | 2020 | 1394 | 0.03 | Why? |
Lipopolysaccharides | 1 | 2018 | 848 | 0.03 | Why? |
Surge Capacity | 1 | 2020 | 894 | 0.03 | Why? |
Prospective Studies | 1 | 2017 | 43301 | 0.03 | Why? |
Propensity Score | 1 | 2020 | 2690 | 0.03 | Why? |
Genetic Variation | 1 | 2005 | 3919 | 0.03 | Why? |
Kaplan-Meier Estimate | 1 | 2020 | 4260 | 0.03 | Why? |
Data Collection | 1 | 2020 | 1769 | 0.03 | Why? |
Coronavirus | 1 | 2020 | 18339 | 0.03 | Why? |
Cross-Sectional Studies | 1 | 2018 | 53120 | 0.03 | Why? |
Infant, Newborn | 2 | 2021 | 23105 | 0.02 | Why? |
Severity of Illness Index | 3 | 2020 | 48226 | 0.02 | Why? |
Antiviral Agents | 1 | 2021 | 41703 | 0.02 | Why? |
Infant | 2 | 2021 | 30274 | 0.02 | Why? |
World Health Organization | 1 | 2020 | 4213 | 0.02 | Why? |
Odds Ratio | 1 | 2019 | 5861 | 0.02 | Why? |
Patient Isolation | 1 | 2020 | 3182 | 0.02 | Why? |
Prognosis | 2 | 2020 | 32490 | 0.02 | Why? |
Child, Preschool | 2 | 2021 | 36283 | 0.02 | Why? |
Korea | 1 | 2005 | 89 | 0.02 | Why? |
Hospitals | 1 | 2005 | 11793 | 0.02 | Why? |
Adolescent | 3 | 2021 | 86841 | 0.02 | Why? |
Bacterial Typing Techniques | 1 | 2005 | 273 | 0.02 | Why? |
Seasons | 1 | 2016 | 4071 | 0.02 | Why? |
Mortality | 1 | 2020 | 7132 | 0.02 | Why? |
Tertiary Care Centers | 1 | 2020 | 8248 | 0.02 | Why? |
Length of Stay | 1 | 2020 | 11042 | 0.01 | Why? |
Disease Management | 1 | 2020 | 6841 | 0.01 | Why? |
Betacoronavirus | 3 | 2020 | 204454 | 0.01 | Why? |
Real-Time Polymerase Chain Reaction | 1 | 2021 | 11367 | 0.01 | Why? |
Case-Control Studies | 1 | 2020 | 17671 | 0.01 | Why? |
Follow-Up Studies | 1 | 2020 | 17020 | 0.01 | Why? |
Disease Progression | 1 | 2020 | 13580 | 0.01 | Why? |
Child | 2 | 2021 | 70012 | 0.01 | Why? |
Host-Pathogen Interactions | 1 | 2020 | 11041 | 0.01 | Why? |
Viral Load | 1 | 2021 | 15850 | 0.01 | Why? |
Young Adult | 2 | 2021 | 93724 | 0.01 | Why? |
Fever | 1 | 2016 | 7795 | 0.01 | Why? |
Mice | 1 | 2018 | 21357 | 0.01 | Why? |
Animals | 2 | 2018 | 78931 | 0.01 | Why? |
Hospital Mortality | 1 | 2020 | 22087 | 0.01 | Why? |
Bacterial Proteins | 1 | 2005 | 1318 | 0.01 | Why? |
Comorbidity | 1 | 2020 | 34796 | 0.01 | Why? |
Incidence | 1 | 2016 | 25622 | 0.01 | Why? |
Antibodies, Neutralizing | 1 | 2021 | 25288 | 0.01 | Why? |
Genotype | 1 | 2005 | 4697 | 0.01 | Why? |
Quarantine | 1 | 2020 | 18418 | 0.01 | Why? |
Antibodies, Viral | 1 | 2021 | 51949 | 0.01 | Why? |
Chang's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(133)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(156)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_